Member Info for Porky9

Can't moneytise any of them before the cash runs out, its that simple.

CLX is a good two or three more discounted raises away and some. The 201 range is 15yrs+ and totally outdated, no peer reviews.

Best you can hope for is a dead cat bounce on some semi lame news that wont have any mention of hard cash being handed over but sounds exciting and might sucker a few in for you to get out on the back of.

Otherwise its a case of waiting a few weeks for the next discounted placing, agreeing to take a chunk at .15 or whatever and offloading into the current share price level at the time. Thats the reality.

You shouldnt be able to run a business where it keeps burning cash, living a champagne lifestyle on other peoples money, deliver nothing in return yet be able to keep coming back time after time to the never ending money tree for placing after placing and then a consolidation event. Clearly you can here.

Be another discounted placing along shortly, so hopefully make a quick kill selling at close to .40 now and buying back to cover in the placing between .10-.15 - we all know how the game is played.

Nick

@OB

"Im not Nick... hes a different guy......"

DOOF DOOF DOOF DOOF DOOOF DUDUDUDU

Trust you are keeping well, staying sane and all that....take care...

Pork's

Stephen,

OK - I'm genuinely trying to help you. The business model they operate with the obscene administration costs that you are paying for with zero revenue delivered is NOT sustainable without continual fund raises.

Trade the stock if you can, offloading should any spikes come your way but for crying out loud don't hold long term because your investment will deminish whilst the BOD fund expensive lifestyles, funding golfing jollys abroad and paying mates ridiculous salaries for effectively part time WFH jobs on YOUR money.

Look, stay in denial if you like, at least I have tried to help you. Oh and BTW i am not Nick, he is a totally different analyst to me.

You take care now.

Stephen,

I am reading your responses to Nick but seriously you are just not getting it. Let me simplify :

Suzy made a disastrous decision in going all in on Labs at the detriment of new evaluations and Mark, friend of Suzy is simply running with the same failed concept. There is NO money in biobanks.

The assets were brought out of Imogen which had also tried to make biobanks viable, failed and went bust. During the last three years Labs at VAL has delivered next to zero revenue. It is labour intensive and AI biotech technology has advanced so much there is little demand for it.

The RNS out confirming partnership with another biobank was painful to read. They are partnering with yet another start up, (no filed accounts yet) no doubt also struggling to get sales.

Meanwhile, admin costs remain obscene- i guarantee you Stephen Mark will be back in a few weeks time fir another chunk of change. He has no choice because he can't get revenue from anywhere else.

The position he inherited was dire, it would take years and many more raises to rebuild an evaluation pipeline from here but running with the failed Labs concept will just accelerate the cash burn. Sorry but I'm not questioning scientific credentials here; I'm questioning basic commercial business acumen: they don't know how to turn a profit heck; they don't know how to raise an invoice yet, its been 15 years with zero revenue.

@Nick

Scenario 1 (best case):-

Ramp the a@se end out of this in the threads, sucker a few newbies in, ME puts some spin news out and you get the hell out on any spike - job done

Scenario 2: (most likely imo):-

Retail now been burnt so much, so may now totally rinsed (is it four or five different brokers now that have promoted this to their client base?) that even the most hardened gamblers wont touch this, results statement out proves continued increasing losses and next placing clear on the horizon and SP continues to drift. Come placing time, selling into .40 to .30 to get placing away at .10 to .20 at best then another consolidation event.

But you know all this, im not telling you something you dont already know, problem is that everyone else has caught on now, game has been played far too much. Do you seriously think that 16+ raises is acceptable? Come on, only on AIM eh...

But, In this current economic climate investors are far more savvy IMO. They are not just chucking cash at anything, its tough times and anyone running even the most basic of Due Dilligence ruler over this can see it for what it is.

To be frank, i dont want to see anyone lose money, you have deep pockets but that doesnt make it right. Its the genuine small investor i feel for, these are people that might not actually have that much liquid cash, they are not earning £200k a year on a part time WFH job but, they think its worth a punt in the hope of a high return whist supporting some "cancer innovation" so they think but really they are being taken for fools - just not nice at all as i see it. Sorry.

And as for the rest of the nonsense in this thread about valuations - seriously you would not pay £1 for the assets because the liabilities to do something with it are obscene - it's a total.liability. Wake up.

Deluded Valuation Nick. Seriously, bio tech with advanced use of AI has advanced so much over the last three years its left VAL standing. This is 15yr old outdated tech you are talking about.

As for Labs and biobank, I previously stated that Natalie runs one major Biobank over at Biograd, guesstimate six times the size of this one powered with donated samples and its run as a charity and it still struggles. IMO this is why ME is trying to package deals with other Biobanks but even then the market is limited - be realistic, Suzy playing Labs brought the samples off Imogen, they were making thumping losses and went bust, its majorly labour intensive work you are talking about so chances of VAL making a profit on these I would say is between no hope and zero. There is no money in it. To further prove the point I'm making ask ME exactly what revenue has Labs invoiced, ie actually paid up during the last three years? Then ask exactly what sales and marketing is being done to secure new invoiced sales?

I get accussed of being a bear here but I'm a total realist - This business is a total lifestyle company, 15+ raises, three 125:1 consolidation and absolutely ZERO revenue in all that time.

Jeeze Nick, in 15 years I could have visited every biotech in the UK to promote VAL and on a pedal bicycle - what have they been doing? They are taking you for a fool.

See what the results statement looks like, guarantee FA revenue again and I'm guessing losses higher than last year - they have no grasp on costs and frankly they don't need to because the cash keeps on coming, no end to it so why worry.

A few months time another £1.5m discoubted raise probably .10- .20 then another consolidation event to get numbers under control and with a bit of spin, pump the SP to sell into it to get it away - jobs a good one. That's how the game is played

Sorry but they will be out of cash long, long before CLX sees light of day of any possible deals. I estimate two to three more raises away.

Shortly results statement out will prove exact cash position. Would not surprise me in the slightest if loses came in higher than last years £2.3m frankly - zero grasp of reality or any form of handle on costs.

"At least cash is not running out very soon..."

ROFLOL if i could post crying with laughter emoji's to that comment i would

See you at the next discounted placing, not long now. Results statement out soon should highlight how little cash runway is left. The current burn is simply not sustainable IMO.

Lol - I am not Nick and I don't work at VAL like i suspect some of the posters here do, nor would I want to, busy enough frankly. Enjoy your Easter

Hold for Gold = more like; Hold for Iron pyrites

Unbelievable .....

Stephen: Seriously, I'm reading your reply to Nick and I would suggest you properly evaluate this. Don't get caught up in biased confirmation.

As i see it, with the current burn, Very soon it's highly likely they will need another heavily discounted share issue to raise £1.5m to keep the lights on and due to the obscene number of shares that will then be in issue will need a forth 125:1 consolidation event to regain a manageable portfolio.

So take the rose specs off and see this for what it is. Nick knows exactly what he's doing, been a bit of a tinker ramping to help own exit but I don't blame him for that, it's dog eat dog out in the market but this lot here are running a lifestyle business and taking amature investors like you for mugs - wake up.

@Nick

1) Agree results historic and nobody will care - however, what they will illustrate is how close they are to the next raise because as sure as light is day, admin costs wont be under control, most likely higher than last year and the remaining cash runway will be shorter, the figures can't lie. NB. Remember @PM2022 (MT employee?) spaffing off just prior to the last three raises how the cash runway was going to last well into the next year, lab revenues would to add to it yada yada, only to find a back deal was being worked on to sell into the stock to get the next placing away. Same old game Nick and well you know it.

2. ME invested £150k yada yada - Yep, pay me £200k with benefits a year and i will do the same whilst i'm running my other businesses as he is. A large number in this company have multiple jobs and work from home, its ridiculous and anyhow, if it goes into administration should it not get another raise (probably will raise at .15 - with stock sold into) he can always buy any assets worth having for a token and reverse them into his other businesses. Win Win.

They are in full on ramp mode because put simply the clocks ticking rapidly towards the next discounted placing, the market knows it and with so many burnt anyone with any sense won’t go near it,

@Nick- - I have maximum respect for you as analyst and appreciate you got sucked into a few on the drop at .40 and likely want to cash them out but your Ramping here is bloody embarrassing joining the other two rampers.

It’s a lifestyle business, it has no control on burn because the money just keeps on coming. 16 raises and three 125:1 consolidations, so spend, spend, spend. The business model doesn’t work, not proven in 15 years not one deal that has brought any cash in and frankly in that time technology has advanced significantly, AI advanced, this is all now in the past. As for labs, no demand for the services, no revenue over the last three years invoiced from labs and nobody employed now in sales to get orders in. Evaluations, totally ignored and so no new pipeline and a new evaluation now is too little too late, it would takes years and more raises to get there, lost time. just like the veterinary vertical, a new evaluation there would be years to come in but ME can use it to try and put some fluff news out just before the next placing to try and spike the SP so brokers can sell into for the placing whilst shafting the PI oblivious to the game.

And you think that if ME sets up a LTD sub coy for an evaluation, issues 60% of the shares to VAL, perhaps a cheeky 20% to himself and 20% perhaps to his mate or someone else, calls it an SPV and puts out an RNS it will catapult the companies value? If it was that easy to increase your value everyone on AIM would be doing it, BUT I do grant you it has worked before and if the SP spikes even for a day, you get to cash out so I totally get you ramping this but I think the market investors now are more sophisticated. They have changed brokers four or five times and rinsed everyone in sight, in 15 years everyone has heard of this penny share, enough is enough.

I don’t know how they got the last two raises away? Daylight robbery frankly, £3m+ quid spunked on board wages and admin costs and jolly’s abroad. Just think what a small business or cancer charity could do with that? Sorry but I’m not a bear because “I want to buy cheaper” I’m a bear because the thought of another John taking his own life needs preventing. They have taken investors for fools, not valued them for too long and enough is enough.

Results statement due out shortly, Do you think the net loss will be lower or higher than £2.1m ? Do you think it will illustrate any sigh of admin costs going up or down? I don’t need a reply as I already can guess the answer: business as usual, spend spend spend, a few more bonus and pay rises here or there and bring on the next discounted raise for more cash because, well why not, it keeps coming, free money and 16 times proves the point.

I have absolutely no time for it

Nice to see a three way ramping session in play - all of it utter tosh to try and sucker some unfortunate newbie in so you can all offload before the inevitable next discounted raise.

@PM - It's been the best part of £35m sqandered on a failed concept over the last 15 years, not 10m - but there are lifestyles to be maintained here.

Appreciate the dire need to ramp though as the window to get out is fast reducing. You have had an uplift from .40 to the current. 50 bid if I were you I would grab it with both hands. This will be .15 at the next placing then the forth 125:1 consolidation event i recon.

Frankly it's ridiculously overvalued for what's there and as for costs need to reduce by another 200k dont make me laugh. More like 1m reduction. He needs to slash admin costs, cut the dead wood and reduce burn to a max of £350k a quarter (1.4m a year) where Kevin had got it to after the previous restructure, before him and suzy got greedy again.

As for the FDA news, anything to ramp this, its totally irrelevant.

Yeah and really funny how share prices tank when MMs have a heavily discounted price in mind to place at and start selling into the stock ahead of it.

And this is exactly what has happened here numerous times, totally shafting small retail investors left scratching their heads why a placing deal was done so cheap and now sitting on a massive loss.

This is because the BOD do not give a toss what the share price is, hence why previous directors never buy, the priority is maintaining £200k a year packages. Maintaining lifestyles.

Frankly with so so many burnt by the countless discounted placing 15+ now and consolidation events 3 now, I'm amazed anyone is even going near these, must be having mad.

For the purpose of debate let me educate you this tine as you are getting carriedcaway with fantasy not reality:-

1- less directors but the best one with any commercial acumen has left and with pay offs you can bet cash burn will come in more than previous years. Let the figures out shortly do the talking g.

2. No it hasn't built a pipeline, that's the issue it was neglected whilst Suzy played at building Labs that don't know what an invoice is. Been three years now, what revenue have they invoiced? Fat Zero.

3. No BDM but MT still delivering zero, just an expensive buddy. Tell me how they will get business in without sales and marketing? It's a competitive landscape out there. Not a chance and results prove it - Zero revenue.

4. Woohoo 200k - so loss might reduce from £2.3 to 2.1m - sorry but massively out of touch.

5. Ambrose has no cash end of. ZERO chance of cash commi g in from it - total fantasy.

6. CLX will be ready for end of year. Wil it now, I doubt it and to even get a deal, the due diligence alone is a 6-9 mth period. I absolutely guarantee no money here will land before at least two more raises if not three. You are seriously deluded if you don't think ME will need another raise later this year to fund it ongoing.

7. Yes jollys, sorry you don't need to fly around the world business class - there is business in the UK and there is zoom, in the last 15 years they could have personally visited every biotech in the UK. What exactly have they been doing?

8. Lab will NOT break even in 2025, pure accounting BS, removing all the admin costs from the calulation does not make it break even - what school of business did you go to? It needs to do £2,3m of revenue + at least for the business to break even, totally impossible. Not a been invoiced in 15 years.

9. The virals - ROFLOL - Let's see one invoiced sale for that £10k , just one. Absolutely no demand imo. Then only another 230 clients at £10k to find to break even but then costs to service would go up as they did at imogen that went bust that they brought off so.probaly need three times that to actually turn in a profit.

Step one, lets see the results statement, I will leave you to keep dreaming and buying the BS and see you at the next discounted placing - not long to go

Stephen

I actually think I'm more qualified to comment as I don't need to ramp this, i can see clearly for what it is. You on the other hand can't because you need to both a) ramp this for self gain and b) prefer an echo chamber of biased confirmation to justify your purchase.

MT or rather Pm2022, not taking on new evaluations is what killed this. Zero pipeline built whilst suzy played Labs. ME is now paying the price for that. Significantly lost both money and time, it will take years to rebuild that pipeline all over again and many more raises, its like starting again. As for "funding not required should 401 or CLX progress" not goi g to happen: 401 Ambrosecare skint members, zero chance of cash from there and not CLX as I already commented, it's yearsxaway and three or four raises away, certainly we outside the current cash runway.

Anyhow, i will leave you both to your ramping - good luck to you.